Able Laboratories Inc (857171) SEC Filing 8-K Material Event for the period ending Friday, August 12, 2005

Able Laboratories Inc

CIK: 857171

View differences made from one to another to evaluate Able Laboratories Inc's financial trajectory

Compare SEC Filings Year-over-Year (YoY) and Quarter-over-Quarter (QoQ)
Sample 10-K Year-over-Year (YoY) Comparison

Compare this 8-K Corporate News to its predecessor by reading our highlights to see what text and tables were  removed  ,   added    and   changed   by Able Laboratories Inc.


Assess how Able Laboratories Inc's management team is paid from their Annual Proxy

Definitive Proxy Statement (Form DEF 14A)
Screenshot example of actual Proxy Statement

Able Laboratories Inc's Definitive Proxy Statement (Form DEF 14A) filed after their 2005 10-K Annual Report includes:

  • Voting Procedures
  • Board Members
  • Executive Team
  • Salaries, Bonuses, Perks
  • Peers / Competitors


SEC Filing Tools
CIK: 857171
Form Type: 8-K Corporate News
Accession Number: 0000914121-05-001553
Submitted to the SEC: Wed Aug 17 2005 2:19:38 PM EST
Accepted by the SEC: Wed Aug 17 2005
Period: Friday, August 12, 2005
Industry: In Vitro And In Vivo Diagnostic Substances
  1. Financial Exhibit
  2. Other Events

External Resources:

Bookmark the Permalink: